Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study

Background: Worldwide, coffee is one of the most popular beverages consumed. Several studies have suggested a protective role of coffee, including reduced risk of Alzheimer’s disease (AD). However, there is limited longitudinal data from cohorts of older adults reporting associations of coffee intak...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Samantha L. Gardener, Stephanie R. Rainey-Smith, Victor L. Villemagne, Jurgen Fripp, Vincent Doré, Pierrick Bourgeat, Kevin Taddei, Christopher Fowler, Colin L. Masters, Paul Maruff, Christopher C. Rowe, David Ames, Ralph N. Martins, the AIBL Investigators
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/630a4aaa35384b7b8e7be42ffd2064af
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:630a4aaa35384b7b8e7be42ffd2064af
record_format dspace
spelling oai:doaj.org-article:630a4aaa35384b7b8e7be42ffd2064af2021-11-19T16:26:56ZHigher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study1663-436510.3389/fnagi.2021.744872https://doaj.org/article/630a4aaa35384b7b8e7be42ffd2064af2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnagi.2021.744872/fullhttps://doaj.org/toc/1663-4365Background: Worldwide, coffee is one of the most popular beverages consumed. Several studies have suggested a protective role of coffee, including reduced risk of Alzheimer’s disease (AD). However, there is limited longitudinal data from cohorts of older adults reporting associations of coffee intake with cognitive decline, in distinct domains, and investigating the neuropathological mechanisms underpinning any such associations.Methods: The aim of the current study was to investigate the relationship between self-reported habitual coffee intake, and cognitive decline assessed using a comprehensive neuropsychological battery in 227 cognitively normal older adults from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) study, over 126 months. In a subset of individuals, we also investigated the relationship between habitual coffee intake and cerebral Aβ-amyloid accumulation (n = 60) and brain volumes (n = 51) over 126 months.Results: Higher baseline coffee consumption was associated with slower cognitive decline in executive function, attention, and the AIBL Preclinical AD Cognitive Composite (PACC; shown reliably to measure the first signs of cognitive decline in at-risk cognitively normal populations), and lower likelihood of transitioning to mild cognitive impairment or AD status, over 126 months. Higher baseline coffee consumption was also associated with slower Aβ-amyloid accumulation over 126 months, and lower risk of progressing to “moderate,” “high,” or “very high” Aβ-amyloid burden status over the same time-period. There were no associations between coffee intake and atrophy in total gray matter, white matter, or hippocampal volume.Discussion: Our results further support the hypothesis that coffee intake may be a protective factor against AD, with increased coffee consumption potentially reducing cognitive decline by slowing cerebral Aβ-amyloid accumulation, and thus attenuating the associated neurotoxicity from Aβ-amyloid-mediated oxidative stress and inflammatory processes. Further investigation is required to evaluate whether coffee intake could be incorporated as a modifiable lifestyle factor aimed at delaying AD onset.Samantha L. GardenerSamantha L. GardenerStephanie R. Rainey-SmithStephanie R. Rainey-SmithStephanie R. Rainey-SmithStephanie R. Rainey-SmithVictor L. VillemagneJurgen FrippVincent DoréVincent DoréPierrick BourgeatKevin TaddeiKevin TaddeiChristopher FowlerColin L. MastersPaul MaruffPaul MaruffChristopher C. RoweChristopher C. RoweDavid AmesDavid AmesRalph N. MartinsRalph N. MartinsRalph N. Martinsthe AIBL InvestigatorsFrontiers Media S.A.articlecoffeeAlzheimer’s diseaseAIBLAustralian Imaging Biomarkers and Lifestyle flagship study of ageingcaffeinecognitive declineNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Aging Neuroscience, Vol 13 (2021)
institution DOAJ
collection DOAJ
language EN
topic coffee
Alzheimer’s disease
AIBL
Australian Imaging Biomarkers and Lifestyle flagship study of ageing
caffeine
cognitive decline
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle coffee
Alzheimer’s disease
AIBL
Australian Imaging Biomarkers and Lifestyle flagship study of ageing
caffeine
cognitive decline
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Samantha L. Gardener
Samantha L. Gardener
Stephanie R. Rainey-Smith
Stephanie R. Rainey-Smith
Stephanie R. Rainey-Smith
Stephanie R. Rainey-Smith
Victor L. Villemagne
Jurgen Fripp
Vincent Doré
Vincent Doré
Pierrick Bourgeat
Kevin Taddei
Kevin Taddei
Christopher Fowler
Colin L. Masters
Paul Maruff
Paul Maruff
Christopher C. Rowe
Christopher C. Rowe
David Ames
David Ames
Ralph N. Martins
Ralph N. Martins
Ralph N. Martins
the AIBL Investigators
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
description Background: Worldwide, coffee is one of the most popular beverages consumed. Several studies have suggested a protective role of coffee, including reduced risk of Alzheimer’s disease (AD). However, there is limited longitudinal data from cohorts of older adults reporting associations of coffee intake with cognitive decline, in distinct domains, and investigating the neuropathological mechanisms underpinning any such associations.Methods: The aim of the current study was to investigate the relationship between self-reported habitual coffee intake, and cognitive decline assessed using a comprehensive neuropsychological battery in 227 cognitively normal older adults from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) study, over 126 months. In a subset of individuals, we also investigated the relationship between habitual coffee intake and cerebral Aβ-amyloid accumulation (n = 60) and brain volumes (n = 51) over 126 months.Results: Higher baseline coffee consumption was associated with slower cognitive decline in executive function, attention, and the AIBL Preclinical AD Cognitive Composite (PACC; shown reliably to measure the first signs of cognitive decline in at-risk cognitively normal populations), and lower likelihood of transitioning to mild cognitive impairment or AD status, over 126 months. Higher baseline coffee consumption was also associated with slower Aβ-amyloid accumulation over 126 months, and lower risk of progressing to “moderate,” “high,” or “very high” Aβ-amyloid burden status over the same time-period. There were no associations between coffee intake and atrophy in total gray matter, white matter, or hippocampal volume.Discussion: Our results further support the hypothesis that coffee intake may be a protective factor against AD, with increased coffee consumption potentially reducing cognitive decline by slowing cerebral Aβ-amyloid accumulation, and thus attenuating the associated neurotoxicity from Aβ-amyloid-mediated oxidative stress and inflammatory processes. Further investigation is required to evaluate whether coffee intake could be incorporated as a modifiable lifestyle factor aimed at delaying AD onset.
format article
author Samantha L. Gardener
Samantha L. Gardener
Stephanie R. Rainey-Smith
Stephanie R. Rainey-Smith
Stephanie R. Rainey-Smith
Stephanie R. Rainey-Smith
Victor L. Villemagne
Jurgen Fripp
Vincent Doré
Vincent Doré
Pierrick Bourgeat
Kevin Taddei
Kevin Taddei
Christopher Fowler
Colin L. Masters
Paul Maruff
Paul Maruff
Christopher C. Rowe
Christopher C. Rowe
David Ames
David Ames
Ralph N. Martins
Ralph N. Martins
Ralph N. Martins
the AIBL Investigators
author_facet Samantha L. Gardener
Samantha L. Gardener
Stephanie R. Rainey-Smith
Stephanie R. Rainey-Smith
Stephanie R. Rainey-Smith
Stephanie R. Rainey-Smith
Victor L. Villemagne
Jurgen Fripp
Vincent Doré
Vincent Doré
Pierrick Bourgeat
Kevin Taddei
Kevin Taddei
Christopher Fowler
Colin L. Masters
Paul Maruff
Paul Maruff
Christopher C. Rowe
Christopher C. Rowe
David Ames
David Ames
Ralph N. Martins
Ralph N. Martins
Ralph N. Martins
the AIBL Investigators
author_sort Samantha L. Gardener
title Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
title_short Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
title_full Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
title_fullStr Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
title_full_unstemmed Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
title_sort higher coffee consumption is associated with slower cognitive decline and less cerebral aβ-amyloid accumulation over 126 months: data from the australian imaging, biomarkers, and lifestyle study
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/630a4aaa35384b7b8e7be42ffd2064af
work_keys_str_mv AT samanthalgardener highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT samanthalgardener highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT stephanierraineysmith highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT stephanierraineysmith highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT stephanierraineysmith highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT stephanierraineysmith highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT victorlvillemagne highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT jurgenfripp highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT vincentdore highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT vincentdore highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT pierrickbourgeat highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT kevintaddei highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT kevintaddei highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT christopherfowler highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT colinlmasters highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT paulmaruff highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT paulmaruff highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT christophercrowe highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT christophercrowe highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT davidames highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT davidames highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT ralphnmartins highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT ralphnmartins highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT ralphnmartins highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
AT theaiblinvestigators highercoffeeconsumptionisassociatedwithslowercognitivedeclineandlesscerebralabamyloidaccumulationover126monthsdatafromtheaustralianimagingbiomarkersandlifestylestudy
_version_ 1718420016257302528